Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures
The Patent and Trademark Office (PTO) is amending the rules for submitting nucleotide or amino acid sequences in computer readable form (CRF) for patent applications. These amendments simplify the requirements of the rules, rearrange portions of the rules for better understanding and establish consistent rules to permit a single internationally acceptable computer readable form. Sequence Listings will be presented in an international, language neutral format using numeric identifiers rather than the current subject headings. The Paper Sequence Listing will preferably be a separately numbered section of the patent application. Sequences which contain fewer than four specifically identified nucleotides or amino acids will no longer be required to be submitted in computer readable form.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/1998/06/01/98-14194/requirements-for-patent-applications-containing-nucleotide-sequence-andor-amino-acid-disclosures (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 1998-06-01
- Document type
- Rule
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Changes Implementing Nucleotide and/or Amino Acid Sequence Listings
- Standard for Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language) in Patent Applications To Implement WIPO Standard ST.26; Incorporation by Reference
- Standard for Presentation of Nucleotide and Amino Acid Sequence Listings Using eXtensible Markup Language (XML) in Patent Applications To Implement WIPO Standard ST.26; Incorporation by Reference
- Standard ST.26-Request for Comments on the Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language)
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Electronic Submission of a Sequence Listing, a Large Table, or a Computer Program Listing Appendix in Patent Applications
- Electronic Submission of a Sequence Listing, a Large Table, or a Computer Program Listing Appendix in Patent Applications
- Request for Comments on the Recommendation for the Disclosure of Sequence Listings Using XML (Proposed ST.26)
- Changes To Permit Delayed Submission of Certain Requirements for Prioritized Examination
- Changes To Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures; Correction
- Changes to Patent Practice and Procedure
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures